DO Dow Jones Newswires Splash Beverage Announces Exclusive Global Licensing Agreement With Argent BioPharma for CannEpil 7/7/2026, 06:15 PM GMT+8 Dow Jones Newswires SB SBEV RG RGT Sources Dow Jones Newswires Active symbols AMEX:SBEV, ASX:RGT Language English Splash Beverage Announces Exclusive Global Licensing Agreement With Argent BioPharma for CannEpil Market News Stocktwits SBEV Stock Tumbles Over 35% In Pre-Market Today — A Look At Its Latest Deal With Argent BioPharma PR Newswire SPLASH BEVERAGE GROUP ACQUIRES EXCLUSIVE GLOBAL RIGHTS TO CANNEPIL®, AN EPILEPSY THERAPY WITH ESTABLISHED EUROPEAN PATIENT ACCESS, FDA ENGAGEMENT AND U.S. DEVELOPMENT POTENTIAL Reuters Argent Biopharma Enters Global Licensing Transaction TradingView Splash acquires exclusive global rights to CannEpil, secures $1M strategic investment
